Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive has built a robust product pipeline that has a particular focus on infectious diseases and rare disorders and is discovering and developing new therapeutic uses of drugs such as Bucillamine, Psilocybin and Cannabidiol. We are steadily advancing our product development programs that will unlock the potential value of Revive and we are continuing to expand our product pipeline in infectious diseases and rare disorders.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (CSE:RVV)

Fundamentals Snapshot (CSE:RVV)

Current News (CSE:RVV)

Revive Therapeutics Submits Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire 12 days ago

Revive Therapeutics To Submit Updated Briefing Package in Support of Upcoming Type C Meeting Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire January 12, 2023

Revive Therapeutics (CSE:RVV) closes $4.3M private placement

John Ballem  January 12, 2023

Revive Therapeutics Ltd. Closes $4.3 Million Offering

GlobeNewswire January 12, 2023

Revive Therapeutics Announces Publication Showing Bucillamine's Potential Impact on COVID-19 Omicron Variants

GlobeNewswire January 9, 2023

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire January 5, 2023

Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

GlobeNewswire December 22, 2022

Revive Therapeutics Ltd. Expands Life Offering to Quebec

GlobeNewswire December 15, 2022

Revive Therapeutics (CSE:RVV) announces $5M private placement

John Ballem  December 1, 2022

Bullboard Posts (CSE:RVV)

RE:RE:RE:RE:RE:RE:RE:$RVV - Interesting Reddit posts !

Due diligence ha!, LoL, how much due diligence do you want, fvcking 3 years worth ha! COOL DA-FOOL!
90guppy - 18 hours ago

RE:RE:RE:RE:RE:RE:$RVV - Interesting Reddit posts !

LoL, another sucker!
90guppy - 18 hours ago

RE:RE:RE:RE:RE:$RVV - Interesting Reddit posts !

How old are you Guppy  Are you 14 years old  Every fuken days you reply , mind you own business and and do you own dilligence...
ginosailling - 18 hours ago

RE:RE:RE:RE:$RVV - Interesting Reddit posts !

COOL DA- FOOL, you got nothing! COOL DA-FOOL!
90guppy - 18 hours ago

RE:RE:RE:$RVV - Interesting Reddit posts !

COOL DA-FOOL, Lol, dont you even try posting that best risk reward ratio, blah blah blah, you should email it to mfrank instead, you...
90guppy - 4 days ago

RE:RE:$RVV - Interesting Reddit posts !

COOL DA- FOOL, that is if you understand the science yourself, talk to mfrank educate him so that rvv doesnt have to rely on useless no...
90guppy - 6 days ago